Leo International Precision Health AG discloses insider share acquisition by board member Leo Wang
Leo International Precision Health AG announced that Leo Wang, a member of its administrative or supervisory body, has purchased shares of the company.
The transaction involved a total consideration of €55,932.50 at a price of €22.373 per share, executed on 27 July 2026 at the Frankfurt Stock Exchange.
The disclosure was made through a regulatory announcement on GlobeNewswire, fulfilling the company’s obligations to report transactions by persons discharging managerial responsibilities.
No further strategic implications or additional financial details were provided in the notice.
This writeup was produced by pharmadog from original reporting by globenewswire health.
Original headline: “Leo International Precision Health AG: Mr Leo Wang, Acquisition”
read at globenewswire health ↗
comments(0)
5-min edit window · permanent after that